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ABSTRACT Several studies have examined the po-
tential biological effects of electromagnetic fields (EMF)
on birds; however, little attention has been paid to
the extremely low frequency (ELF; 0–300 Hz; 0–50
μT) radiation found in an urbanized environment.
For monitoring the effects of ELF EMF, we used a
turkey (Meleagris gallopavo) model, because the nucle-
ated erythrocytes of turkeys contain β-adrenoceptors,
and norepinephrine- (NE-) activated β-adrenoceptors
have an important role in physiological and behav-
ioral processes. Our aims were the following: 1) to in-
vestigate the intracellular mechanisms; 2) to compare
the intracellular mechanisms in the treated and con-
trol groups over time, considering inter-individual dif-
ferences and intra-subject correlations; 3) and to study
the reversible nature of the response. The turkeys in
the treatment group were treated in vivo with ELF
EMF (50 Hz; 10 μT) for 3 wk after a 1-wk-long adap-
tation period. The animals were not exposed to ELF
EMF during the regeneration period (5 wk following the
exposure). The NE-activated β-adrenoceptor function
was detected by measuring the amount of 3′5′-cyclic-
adenosine-monophosphate (cAMP), and the biochem-
ical enzyme parameters were defined. Repeated mea-
surements of cAMP levels were analyzed using marginal
models and a piecewise linear mixed model to compare
treatment and control groups over time. According to
our results, NE-activated β-adrenoceptor function was
decreased in the treated birds in a time-dependent man-
ner, while there were no differences between toxicolog-
ical parameters in the serum, compared to the normal
ranges. The decreased NE-dependent β-adrenoceptor
function could be compensated by the homeostatic
complex during the 5-wk regeneration period. Extended
experimental periods and more sophisticated analysis
methods may help prevent harmful environmental ef-
fects on birds; furthermore, these findings could affect
public health and the economy.
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INTRODUCTION
Spontaneous electromagnetic radiation (20 to 30 μT)
has an effect on the natural selection of living organisms
on Earth. Natural electromagnetic background radia-
tion has been altered by technological inventions and
innovations of modern civilization via extensive use of
electric devices, which has resulted in increased electro-
magnetic fields (EMF).
There are several pieces of literature examining the
potential biological effects of EMF (radiofrequency, mi-
crowaves); however, very few of them deal with the is-
sue of whether and how extremely low frequency (ELF)
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radiation puts the welfare of humanity and/or the en-
vironment at any risk (Santini et al., 2009; Cifra et al.,
2011). ELF EMFs are defined as frequencies between 0
to 300 Hz (Feychting et al., 2005; Funk et al., 2009).
Living organisms maintain equilibrium with their en-
vironment by adapting to changing external and inter-
nal circumstances. Behavior is a rapid biological answer
to the environmental stimuli that can be detected easily,
and it is investigated with relation of cause and effect of
homeostatic physiological processes (Kavet and Banks,
1986; Palanza et al., 2008; Nagyeri et al., 2012).
In higher vertebrates, such as birds or mammals, the
homeostatic physiological processes can be regulated at
the cellular level by membrane function. Membrane po-
tential has a role in the continuance of membrane func-
tion; therefore, examining membrane function in physi-
ological processes and behavior is relevant. In this field
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the role of norepinephrine (NE) can be emphasized
as the common mediator of behavior and physiological
functions.
Monoaminergic trajectories play an important role
in vegetative functions, such as regulation of the car-
diovascular system and food uptake, thermostatic con-
trol, and circadian rhythm, and in the formation of be-
havior patterns seen in depression and anxiety (Ressler
and Nemeroff, 2000). NE and its metabolites measured
in urine, blood, and cerebrospinal fluid are elevated in
panic disorders, post-traumatic stress disorders, special
phobias, social anxiety, and generalized anxiety dis-
orders, presenting a dysregulation of central and pe-
ripheral NE systems (Uhde et al., 1984; Ressler and
Nemeroff, 1999).
Birds have been widely used for monitoring the en-
vironmental significance of exposure to nonionizing ra-
diation (Balmori, 2009; Tomas et al., 2012). In the cur-
rent study, a turkey (Meleagris gallopavo) model was
designed to investigate the biological effects of physical
parameters (frequency, field force) that are representa-
tive of commercially available electromagnetic devices.
Turkeys were examined because they have nucleated
erythrocytes, which can be used in studies of morpho-
logical changes at cellular level and are easy to sep-
arate. Nucleated erythrocytes of turkeys constitute a
suitable model system for studying several ion trans-
ports and signal processes (Rudolph and Greengard,
1974). The erythrocyte membrane of turkeys contains
β-adrenergic receptors, which are related to the 3′5′-
cyclic-adenosine-monophosphate (cAMP) second mes-
senger system (Gardner et al., 1975). β-adrenergic cat-
echolamines (NE, epinephrine) can also enhance the in-
tracellular cAMP level of the erythrocytes (Sutherland
and Robison, 1966; James et al., 1994).
The effect of ELF EMF on the behavior of birds is
detectable, but the results are inconsistent. The natural
reversibility of cell functions is a remarkable fact that
indicates the operation of a proper homeostatic system
that can be worsened or improved by ELF EMF treat-
ment. In the literature survey, the authors could not
find any example of such a complex investigation for
the detection of natural reversibility of cell functions
after ELF EMF exposures.
Our research had multiple objectives:
1) We aimed to demonstrate the effect of in vivo ELF
EMF treatment on in vitro levels of NE-activated
β-adrenoceptor function of physiological processes
as cellular mechanisms by taking parallel blood sam-
ples from treatment groups so as to verify result in-
terpretation.
2) Our purpose was to estimate the means of cAMP
levels in ELF EMF treated and untreated groups
at distinct points in time to detect the differences
at the level of NE-activated β-adrenoceptor mecha-
nisms. Moreover, we aimed to characterize the rate
of change in β-adrenoceptor function over time,
while considering inter-individual differences and
suitable intra-subject correlation structure.
3) In addition, our aim was to design the above men-
tioned experimental system to be able to point
out the reversible nature of the response (β-




Female adult turkeys (from state farm, weight 5,000
to 5,200 g) with veterinary certificates were used as the
model system. The animal care and research protocols
were in full accordance with the guidelines of the Uni-
versity of Szeged, Hungary.
Four animals served as control (one absolute con-
trol that was untreated; one positive control for which
equipment was in standby mode; one negative control
for which the machine was switched off; and one sham
control that went through the protocol without receiv-
ing any EMF exposure). Forty animals were treated
with intermittent ELF EMF. The animals were indi-
vidually numbered.
Experimental Conditions
The turkeys were kept together during the exper-
imental process except the treatment time. For the
treatment, they were put separately in metal-free cages.
At the beginning of the experiment, the animals were
conditioned for 1 wk (adaptation period) to eliminate
the possibility of stress effects caused by the new sur-
roundings, animal caregiver, food, etc.
Extremely Low Frequency Electromagnetic
Field Treatment
The treatment was performed using a special unit de-
signed for the generation of pulsed ELF EMF (8 ms en-
ergy exposure – 2 ms energy free pause). During treat-
ment, the cages were covered by a 200 cm × 80 cm
“magnetic blanket” that was operated by the Hun-
garian electric regulation (U = 220 V, ν = 50 Hz).
The turkeys were exposed to ν = 50 Hz (controlled
by an electromagnetic equipment: ME3951A Low fre-
quency (NF) analyzer, Gigahertz Solutions, Germany),
B = 10 μT (checked by the PCE-EMF823 Electromag-
netic Field Radiaton Tester, Tursdale Technicale Ser-
vices Ltd, UK) intermittent ELF EMF treatment for
20 min every 8 h for the 3 wk of the experimental
period.
ELF EMF Experimental Model
In Vivo Experiments (Figure 1/A)
Monitoring of Behavior The animals were regu-
larly observed for physical activity (relaxation, play,
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Figure 1. Structure of the ELF EMF experimental model. Notations: ELF, extremely low frequency; EMF, electromagnetic field; AC,
absolute control; +C, positive control; −C, negative control; SC, sham control; cAMP, 3′5′-cyclic-adenosine-monophosphate; NE, norepinephrine;
P, propranolol.
behavior, competition, aggression) and food and water
consumption (Ficken and Ficken, 1966).
Blood Samples Heparinized blood samples were
taken from the subclavian vein at the same time ev-
ery wk during the examination. All measurements per-
formed 4 to 6 technical parallels. Blood samples were
separated by centrifugation for 5 min at 2,000 rpm. Af-
ter removing the plasma, the red blood cells (RBC)
were washed 3 times with 0.9% saline solution. At the
end of the procedure, the erythrocytes were suspended
in Ringer-solution buffered by 10 mM TRIS/HCl; pH
7.4 and the hematocrit value was 20%.
Toxicological Monitoring from Turkey Blood-Serum
Enzyme Measurements During the experiment, the fol-
lowing biochemical enzyme parameters were measured
from the blood: serum glutamic-oxaloacetic transam-
inase (SGOT) (Remaley and Wilding, 1989), serum
glutamic-pyruvic transaminase (SGPT) (Matsuzawa
et al., 1997), alkaline phosphatase (AP) and gamma-
glutamyl transpeptidase (γGT) with Dialab methods
(DIALAB production, Austria). Lactate dehydrogenase
(LDH) activity was also measured (Remaley and Wild-
ing, 1989).
In Vitro Experiments (Figure 1/B)
Incubation Protocol In the first in vitro experimental
step, the baseline of intracellular cAMP was determined
from all blood samples of the turkeys. For the study
of the activation of β-adrenergic receptor, an agonist
([NE] = 10−6 M; t = 30 min) as well as an antagonist
(propranolol (P): [P] = 10−6 M; t = 30 min) were used
separately and combined. Combination means that the
agonist was added at a concentration of 10−6 M to
the erythrocytes following a 30 min preincubation with
the antagonist at a concentration of 10−6 M. In all pro-
cedures, the intracellular cAMP level was measured af-
ter incubation.
Hemoglobin Determination The hemoglobin was
transformed into cyanohemoglobin which was detected
photometrically (λ = 540 nm) (O’Halloran et al., 1987).
Determination of cAMP Level In vitro samples were
taken from RBC suspension (SUSP) of turkeys. These
were denatured at 100◦C for 3 min, and were kept at
−20◦C until further use. Before cAMP determination,
the samples were defrosted and precipitated (at 0◦C,
1600 rpm, t = 1 min). The cAMP content of samples
was quantitated by competitive binding assay (Amer-
sham cAMP Biotrak EIA system, GE Healthcare, UK).
Statistical Analysis
Means were calculated from technical replicates for
each subject (experimental unit: turkey), and used for
analyses of cAMP levels (as markers of β-adrenoceptor
function). Descriptive statistics (mean, SD, n, mini-
mum, median, maximum) were calculated to identify
distribution of cAMP levels by treatment groups and
time points (Supplemental Table 1 (Table S1)).
To verify the β-adrenoceptor function in the in
vitro experimental model during the adaptation period
(wk 1), cAMP levels were compared between groups of
base, NE, P and P+NE, based on linear mixed model
using random intercept for the subjects (Singer and
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Willett, 2003; SAS, 2011). Mean cAMP levels of n = 40
animals (selected for ELF EMF treatment from wk 2)
and SEs are presented.
To compare NE-activated β-adrenoceptor function of
control animals (n = 4) to the average cAMP levels of
turkeys (n = 40 and n = 44) at the adaptation period
(wk 1), one-sample t-tests were applied. 95% CIs are
presented with means and P-values (P).
Effects of ELF EMF treatment on NE-activated
β-adrenoceptor function were analyzed using a linear
mixed model where cAMP levels of the treatment pe-
riod (wk 2–4) as repeated measures of treated ani-
mals (n = 40) were compared to the adaptation period
(wk 1).
To estimate means in ELF EMF treated and un-
treated groups over time in the whole experimental pe-
riod (wk 1–9) considering between-subject differences
and within-subject correlation, marginal model was ap-
plied using unstructured covariance structure (Zeger et
al., 1988; Hamer and Simpson, 2000; Littell et al., 2000;
Singer and Willett, 2003; SAS, 2011; Hayat and Hedlin,
2012). Differences of least squares means are calculated
according to Sidak’s adjustment.
To characterize the reversible nature of NE-activated
β-adrenoceptor function after ELF EMF treatment by
the rate of change in time, piecewise linear mixed model
was used, which could describe the linear trajectories
of cAMP levels in the treatment and in the regenera-
tion periods (Naumova et al., 2001; Singer and Willett,
2003; Curran et al., 2010). An intraclass correlation co-
efficient was calculated to describe variation (Dickey,
2008).
In marginal and mixed models, the restricted max-
imum likelihood estimation method was used with
unstructured covariance structure. Kenward-Roger’s
method was applied for adjusting df. Model residuals
were checked for normality. All statistical analyses were
performed using SAS (Version 9.3 SAS Institute Inc.,
Cary, NC, USA), with Type I error α = 0.05.
RESULTS
In Vivo and In Vitro Combined Experimental
Model
According to our observations, turkeys were more
inactive depending on the duration of in vivo ELF
EMF exposure. They did not show an interest in each
other, scratched less, fluffed up their feathers, slept
more, and huddled at the back of the enclosure. De-
spite the depression-related behavior, the ELF EMF
had no effect on blood biochemical parameters (con-
tent of hemoglobin, SGOT, SGPT, AP, γGT, LDH).
These results supported the assumption that the 10
μT exposure was subtoxic. Standard, combined ex-
perimental model was used to investigate the physi-
ological background of behavior deviation. After the
in vivo exposure, the function of β-adrenoceptors was
detected in the in vitro functional model, which was
performed.
To verify functionality of the in vitro model, the ef-
fect of the agonist (NE) was compared to the baseline,
to the antagonist (P) and to P+NE of β-adrenoceptors
(Figure 2). Multiple elevated levels of cAMP were de-
tected following NE incubation under normal condi-
tions. When P treatment was applied before NE admin-
istration, the NE-induced level of cAMP increase was
blocked (mean ± SE cAMP (nmol/mL RBC SUSP):
Base: 1.08 ± 0.02, NE: 16.60 ± 0.27, P: 1.13 ± 0.01,
P+NE: 1.08 ± 0.02; P < 0.001 in comparison to NE vs.
Base, NE vs. P and NE vs. P+NE). There were no dif-
ferences (P > 0.99) between any other pairs of groups
of Base, P or P+NE.
The intracellular levels of cAMP were determined
from the blood samples for supporting the function-
ality of β-adrenoceptor in the examination protocol at
the end of the adaptation period. Thus, all data could
be used as self-control and also as untreated control at
this time. Comparison of the mean cAMP level of the
control group (absolute control; positive control; nega-
tive control; and sham control) to the ones at the adap-
tation period did not show a difference in the combined
experimental model (Supplemental Table 2 (Table S2),
P > 0.3).
The effects of in vivo ELF EMF exposure were de-
tected by the in vitro β-adrenoceptor functional model.
The effect of 10 μT ELF EMF in vivo treatment on
the NE-activated β-adrenoceptor mediated intracellu-
lar level of cAMP is depicted in Figure 3.
Compared to the untreated response of the adapta-
tion period, the β-adrenoceptor mediated cAMP levels
were decreased (P < 0.001) during the time of the ELF
EMF treatment (Figure 3).
Characterization of ELF EMF Treatment on
NE-activated β-adrenoceptor Functions
Over Time
The effect of ELF EMF was significant over time
compared to the control group during wk 3–5 (differ-
ences: wk 3: 4.04 with 95% CI of [0.66; 7.41]; wk 4: 8.29
with 95% CI of [5.61; 10.97]; wk 5: 5.66 with 95% CI of
[2.08; 9.24] measured in nmol cAMP/mL RBC SUSP;
P < 0.01; Supplemental Table 3 (Table S3)). The val-
ues of the control group did not change (16.7 nmol
cAMP/mL RBC SUSP with the 95% CI of [15.3; 18.2])
throughout the whole experiment (Figure 4; Supple-
mental Table 3 (Table S3)).
The cAMP level of subjects in the ELF EMF treated
group had a decrease (P < 0.001) of 2.6 nmol/mL
RBC SUSP per wk (95% CI: [−2.8; −2.4]) in the treat-
ment period, while there was an increase (1.5 nmol
cAMP/mL RBC SUSP per wk; 95% CI: [1.2; 1.9]; P
< 0.001) in the regeneration period (Figure 4; Supple-
mental Table 3 (Table S3)). At the intercept of the 2
fitted linear pieces (wk 4), the mean cAMP level was
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Figure 2. Verification of in vitro experimental model for NE-activated β-adrenoceptor function at adaptation (wk 1, no
ELF EMF exposure). Mean (cAMP levels) ± SE at adaptation (wk 1). Mean and SE are calculated on n = 40 animals (treated group from
wk 2). Notation: ELF, extremely low frequency; EMF, electromagnetic field; cAMP: 3′5′-cyclic-adenosine-monophosphate; Base, baseline; NE,
norepinephrine; P, propranolol; nmol/mL, nmol cAMP/mL RBC SUSP; RBC, red blood cell; SUSP, suspension. ∗∗∗indicates difference between
pairs of NE and all other groups with Type I error α = 0.001.
Figure 3. Effects of in vivo ELF EMF treatment on the NE-activated β-adrenoceptor function. Mean NE-activated cAMP levels
with SE during treatment period (wk 2–4). Reference lines represent mean cAMP (nmol/mL RBC SUSP) level at the adaptation period (wk 1)
for baseline (lower) and NE-activation (upper). Notation: ELF, extremely low frequency; EMF, electromagnetic field; NE, norepinephrine; base,
baseline; cAMP: 3′5′-cyclic-adenosine-monophosphate, RBC, red blood cell; SUSP, suspension. ∗∗∗indicates difference from NE-activated cAMP
level at the adaptation (wk 1) with Type I error α = 0.001.
9.6 nmol/mL RBC SUSP in the treated group, which
was 7.1 nmol/mL RBC SUSP (95% CI: [-8.6; -5.5]) less
than that of the control group (16.7 nmol/mL RBC
SUSP, Figure 4; Supplemental Table 3 (Table S3)). As
60% of the variation of cAMP levels comes from in-
dividual characteristics of turkeys, 40% is from within
subject effects.
The Reversible Nature of the Biological
Experimental Model
After the treatment with ELF EMF, the main ques-
tion was whether or not the biological system (NE-
activated β-adrenergic receptor function) was capa-
ble of returning to the starting state. Furthermore,
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Figure 4. Fitted analysis model for the complete experiment. Result of piecewise linear mixed model. Dashed thick, black lines
represent predicted means. Dashed dark grey lines show individual trajectories. Notations: + control (n = 4), o treated (n = 40) subjects, cAMP,
3′5′-cyclic-adenosine-monophosphate; NE, norepinephrine; nmol/mL, nmol cAMP/mL RBC SUSP; RBC, red blood cell; SUSP, suspension.
a relevant question was whether, and if so, how this
capacity was modified during the treatment. For this
reason, the NE-activated β-adrenoceptor function was
investigated weekly, over the regeneration period. The
alterations of the β-adrenoceptor function are demon-
strated during the experimental period (adaptation,
ELF EMF treatment, regeneration) in Figure 4 and
Supplemental Table 3 (Table S3). The measured NE-
activated levels of cAMP were in compliance with the
normal parameters at the end of the adaptation period.
The piecewise linear mixed model revealed a decreased
effectiveness of β-adrenoceptors, as the NE-activated
cAMP level was getting lower and lower during the
treatment with ELF EMF. After the end of the ELF
EMF treatment, the β-adrenoceptor functions returned
to the starting state in 5 wk. As mentioned above, the
recovery (increase) of β-adrenoceptor functions in the
treated group was slower in the regeneration period
(slope of cAMP: 1.5 nmol/mL RBC SUSP) compared
to the rate of decrease (slope of cAMP: −2.6 nmol/mL
RBC SUSP) in the treatment period (Figure 4; Supple-
mental Table 3 (Table S3)). The treated group did not
differ from the control at the end of the regeneration
period (wks 6 to 9, P ≥ 0.15; Supplemental Table 3
(Table S3)).
DISCUSSION
The effect of ELF EMF has been investigated from
many aspects previously, using repeated measurements
to characterize the pattern of the examined indica-
tor over time: breeding and migrating behavioral as-
pects of birds (Hanowski et al., 1996), hematological pa-
rameters in mice (Bonhomme-Faivre et al., 2004), and
melatonin levels in calves (Kolbabova´ et al., 2015).
However, behavioral patterns defined by receptor func-
tions using mixed models have been rarely considered.
Repeated measures experiments have been used com-
monly in animal, plant, and human research for sev-
eral decades, and computing methodologies have been
available to analyze them effectively and efficiently in
the last few decades (Littell et al., 1998).
In our study, we aimed to confirm the effect of in
vivo 10 μT ELF EMF treatment on the NE-activated
β-adrenoceptor function of physiological processes as
cellular mechanisms. The interpretation of our results
was verified by parallel and repeated measurements.
There were no missing values in our measured data, al-
though mixed models can be used on longitudinal data
with missing values (Sapp et al., 2004).
During the experiment, we monitored the serum tox-
icological parameters (content of hemoglobin, SGOT,
SGPT, AP, γGT, LDH), in which there were no dif-
ferences compared to the normal ranges. According to
our observations, the turkeys showed depression-
related behavior (less scratching and picking,
sleeping more, tucking their heads under their
wings) during the ELF EMF treatment. To prove the
involvement of NE-dependent β-adrenoceptor function
(Takenaka et al., 2012; Guereschi et al., 2013; Zhang
et al., 2013; Takenaka et al., 2016) regarding the
physiological background of disinterested behavior,
an experimental model (Figure 1) was performed
(Anisman and Zacharko, 1990; Ressler and Nemeroff,
2001). The in vivo exposition model of turkeys was
carried out with a technologically and methodologically
standardized in vitro model (Figure 2). In line with the
literature (Davoren and Sutherland, 1963; Yin et al.,
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Figure 5. NE-activated β-adrenoceptor cycle (attractor). Notations: P, propranolol; NE, norepinephrine; GTP, guanosine triphosphate;
ATP, adenosine triphosphate; cAMP, 3′5′-cyclic-adenosine-monophosphate. Figure modified after J. Hernandez and Wachter and Gilbert (Wachter
and Gilbert, 2012).
2016), intense effects were observed on NE-activated
β-adrenergic receptors (Figure 2), which verified the
model’s applicability in the study of functional cycling
of NE-activated β-adrenoceptor (Figure 5).
Alteration of behavioral patterns by a 3-wk-long
10 μT ELF EMF treatment was explored by statisti-
cal analyses, which were correlated with the decrease
of NE-activated β-adrenoceptor function (Figure 3; ob-
jective 1). We confirm previous findings, that the de-
creased NE-activated β-adrenoceptor function has an
important role in the formation of emotional disinter-
est and depression (Morilak and Frazer, 2004; Moret
and Briley, 2011).
The difference in sample size (4 vs. 40) of the in-
vestigated groups, could cause biased estimates. Differ-
ent statistical methods were applied that basically had
the same result concerning the significant effect of ELF
EMF over time (Figure 4; objective 2).
Additionally, fitting piecewise linear mixed model to
the data, the treatment and regeneration periods could
be characterized separately, which reflected a sharp
linear reduction in NE-activated β-adrenoceptor func-
tion in the treatment period, and then a remarkable—
likewise linear—growth in the regeneration period (Fig-
ure 4; objectives 2–3). In another study, piecewise linear
model was also applied on poultry-related data (Zuid-
hof et al., 2009).
Besides the statistically verified effect of ELF EMF,
it was important to investigate another interesting
phenomenon. Namely, whether the biological cycle
(which determines receptor function) was able to return
spontaneously—supported by the homeostatic regula-
tory complex (Holling, 1973; Albert et al., 2000)—to its
starting condition, after the treatment period. There-
fore, the chosen indicators of our experimental protocol
were followed up in the regeneration period after the
treatment period. Figure 4 and Supplemental Table 3
(Table S3) depict the success of the regeneration.
In our experiment (neuro-endocrine-immune regula-
tion), turkeys are homeostatic complexities, that are
defined as living biological system networks (Barabasi
and Albert, 1999). Elementary attractors of complex
networks respond to the changing surroundings (as-
sumptions) by performing various operation character-
istics (Luque and Ferrera, 2000). This was proved by
the biological response of turkeys to ELF EMF exposi-
tion. The level of the indicator (intracellular cAMP)
decreased and so represented loss of function under
the effect of ELF EMF. However, the examined NE-
dependent β-adrenoceptor attractor was converged to
the starting condition in the regeneration period by
the support of the in vivo homeostatic complex net-
work. At the same time, data of the control system
reflect no induced alteration. Little disturbance was
induced in the NE-activated β-adrenoceptor attractor
by the chronic effect of ELF EMF treatment, which
was proved by the reversibility. It is important to note
that the reversible disturbance of the NE-dependent
β-adrenoceptor cycle—caused by a 3-wk-long treat-
ment period—was able to be compensated for by the
8 LASZLO ET AL.
homeostatic complexity during the 5 wk in the regener-
ation period (objective 3). Such extensive in vivo and in
vitro experiments combined with sophisticated analysis
methods could be useful in environmental studies, may
help prevent harmful environmental effects, and could
affect public health and the economy.
SUPPLEMENTARY DATA
Supplementary data are available at PSCIEN online.
Table S1. Descriptive statistics of cAMP levels
(NE-activated β-adrenoceptor function) by treatment
groups over time.
Table S2. Comparison of cAMP levels (NE-
activated β-adrenoceptor function) of control animals
in the adaptation period.
Table S3. Estimations of the marginal model (a) and
of the piecewise linear mixed model (b) on the cAMP
levels (NE-activated β-adrenoceptor function).
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